CHU Nantes, Nantes, France ; Université de Nantes, Nantes, France.
CHU Bordeaux, Bordeaux, France ; Bordeaux Segalen University, Bordeaux, France.
United European Gastroenterol J. 2013 Jun;1(3):140-50. doi: 10.1177/2050640613484021.
The treatment of GORD has been revolutionized by the introduction, in the 1980s, of proton-pump inhibitors as the mainstay of medical therapy and by the development of laparoscopic antireflux surgery which has definitively replaced open surgery. However, despite these major advances, many unmet therapeutic needs still persist and justify novel therapeutic approaches. The aim of this historical review is to recall the main discoveries in the treatment of GORD that have occurred during the last three decades and to discuss why some initially promising drugs or techniques have not translated into clinical applications. A careful analysis of these previous disappointing experiences should help to identify high priorities and better research programmes on the management of GORD.
胃食管反流病(GORD)的治疗在 20 世纪 80 年代发生了革命性的变化,质子泵抑制剂(PPI)作为主要的药物治疗方法被引入,腹腔镜抗反流手术也得到了发展,该手术已明确取代了开放性手术。然而,尽管取得了这些重大进展,但仍存在许多未满足的治疗需求,这需要新的治疗方法。本历史回顾的目的是回顾过去三十年中在 GORD 治疗方面的主要发现,并讨论为什么一些最初有希望的药物或技术尚未转化为临床应用。仔细分析这些以前令人失望的经验,应有助于确定 GORD 管理方面的高优先级和更好的研究计划。